Funding Received
$4.1 Million in 1 Round from 2 Investors
Most Recent Funding
$4.1 Million on March 29, 2007 / Undisclosed Round
Headquarters:
Çan
Description:
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with Type II Diabetes.
Categories:
Biotechnology
Website:
http://prognomix.com

Detailed Description

Update

Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.

Funding Rounds (1) - $4.1M

Update

Investors (2)

Update
  • Bf2333d0da2fdd635613e46f9ebcad9b

    BDC Venture Capital

    BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the...
  • Cb default image

    Picchio Pharma

    Picchio Pharma engages in acquiring, developing, and commercializing new therapeutic products and...

Offices/Locations (1)

Update
  • Office

    4101, rue Molson, bureau 201

    Montreal (Quebec)

    Çan, H1Y 3L1

    TUR

Images (1)

Update
  • 63f644207b8c606b4c4b3a69a6f28068